Unique ID issued by UMIN | UMIN000030831 |
---|---|
Receipt number | R000034780 |
Scientific Title | Evaluation of the disolution and palatability of amlodipine orally disintegrating tablet in oral cavity for development of quantitative evaluation methods of palatability by an electronic gustatory system |
Date of disclosure of the study information | 2018/01/16 |
Last modified on | 2019/02/02 16:55:25 |
Evaluation of the disolution and palatability of amlodipine orally disintegrating tablet in oral cavity for development of quantitative evaluation methods of palatability by an electronic gustatory system
Disolution in the oral cavity and palatability of amlodipine orally disintegrating tablet
Evaluation of the disolution and palatability of amlodipine orally disintegrating tablet in oral cavity for development of quantitative evaluation methods of palatability by an electronic gustatory system
Disolution in the oral cavity and palatability of amlodipine orally disintegrating tablet
Japan |
Healthy volunteers
Not applicable |
Others
NO
The aim of this study is to evaluate the elution behavior in the oral cavity and palatability of amlodipine (5 mg) orally disintegrating tablets (ODTs) with physical and gustatory masking for clarifying the effects of physical and gustatory masking
Others
The aim of this study is to evaluate the relationship between
1. The elution volume of amlodipine in the oral cavity and in vitro studies
2.The clinical VAS scores of palatability in the human gustatory sensation test and the electronic gustatory system
for verifying the validity of quantitative evaluation methods of palatability by an electronic gustatory system
Exploratory
Pragmatic
Not applicable
The relationship between the clinical VAS scores of palatability in the human gustatory sensation test and the electronic gustatory system
Elution volume of amlodipine in the oral cavity
Saliva volume
VAS score(overall palatability)
VAS score(bitterness/sweetness)
5-point scale(palatability)
Interventional
Cross-over
Randomized
Individual
Single blind -participants are blinded
Dose comparison
NO
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
6
Treatment
Medicine |
COAO:Amlodipine ODT without taste-masking
C4A0:Physical masking(4%) of Amlodipine ODT
C6A0:Physical masking(6%) of Amlodipine ODT
C6A2:Physical masking(6%) of Amlodipine ODT with a sweetener(2%)
C6A4:Physical masking(6%) of Amlodipine ODT with a sweetener(4%)
C10A0: Physical masking(10%) of Amlodipine ODT
20 | years-old | <= |
65 | years-old | >= |
Male and Female
Healthy adult
1. Clearly taste disorder
2. Allergy for drugs
3. Pregnant and/or lactating women
4. Other who was decided as inadequate by doctor
10
1st name | |
Middle name | |
Last name | Naoki Inui |
Hamamatsu University School of Medicine
Department of Clinical Pharmacology and Therapeutics
1-20-1, Hanadayama, Higashi-ku, Hamamatsu
053-435-2385
inui@hama-med.ac.jp
1st name | |
Middle name | |
Last name | Chiaki Kamiya |
Hamamatsu University School of Medicine
Department of Clinical Pharmacology and Therapeutics
1-20-1, Hanadayama, Higashi-ku, Hamamatsu
053-435-2385
ilka122@hama-med.ac.jp
Hamamatsu University School of Medicine
This work was supported by JSPS KAKENHI Grant Number JP17K08454.
Other
Department of Pharmacy Practice and Science, School of Pharmaceutical Sciences University of Shizuoka
NO
浜松医科大学(静岡県)
2018 | Year | 01 | Month | 16 | Day |
Published
Completed
2017 | Year | 12 | Month | 15 | Day |
2018 | Year | 01 | Month | 16 | Day |
2018 | Year | 01 | Month | 16 | Day |
2019 | Year | 02 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034780